Janez, Andrej |
| Completed | 4 | 90 | Europe | Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG | General and Teaching Hospital Celje | Endothelial Dysfunction, Diabetes Mellitus, Type 1, Biomarkers, Endothelial Progenitor Cells, SGLT 2 Inhibitors, Incretins, Glucose Excursions, FMD, FPF, Arterial Stiffness | 03/22 | 04/23 | | |
E-SEMPA, NCT06613854: Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes |
|
|
| Recruiting | 4 | 90 | Europe | Oral semaglutide, Rybelsus, Empagliflozin 10 mg, Jardiance | University Medical Centre Ljubljana | Type 2 Diabetes Mellitus (T2DM) | 09/27 | 12/27 | | |
| Recruiting | 1/2 | 10 | Europe, US | Semaglutide | University Medical Centre Ljubljana, Stanford University, Greenstone Biosciences | Heart Failure, Obesity | 07/25 | 09/25 | | |
Vrtovec, Bojan |
| Completed | 4 | 1105 | Europe | Iron, Saline, salin | Universitätsklinikum Hamburg-Eppendorf, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Charite University, Berlin, Germany | Systolic Heart Failure, Iron Deficiency | 05/24 | 05/24 | | |
| Completed | 2 | 30 | Europe | Cell Therapy | University Medical Centre Ljubljana | Heart Failure With Normal Ejection Fraction | 01/22 | 03/22 | | |
CELL-VAD, NCT06154044: Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support |
|
|
| Recruiting | 2 | 10 | Europe | CD34+ stem cell therapy | University Medical Centre Ljubljana | Heart Failure, Mechanical Circulatory Support | 12/24 | 05/25 | | |
| Completed | 2 | 49 | Europe | PROTHERACYTES, Standard Treatment for CHF post AMI | CellProthera | Acute Myocardial Infarction | 03/24 | 03/24 | | |
| Recruiting | 2 | 90 | Europe | Letermovir Pill | University Medical Centre Ljubljana | CMV Viremia | 08/25 | 08/26 | | |
NCT03797092: Stem Cell Therapy in Non-IschEmic Non-treatable Dilated CardiomyopathiEs II: a Pilot Study |
|
|
| Recruiting | 1/2 | 30 | Europe | Allogeneic adipose-derived stromal cells (CSCC_ASC), Investigational medicinal product, Control group | JKastrup, University Medical Centre Ljubljana | Non-ischemic Dilated Cardiomyopathy | 07/21 | 09/21 | | |
| Recruiting | 1/2 | 40 | Europe | Genistein | University Medical Centre Ljubljana, Greenstone Biosciences | Heart Failure | 07/26 | 09/26 | | |
| Recruiting | 1/2 | 10 | Europe, US | Semaglutide | University Medical Centre Ljubljana, Stanford University, Greenstone Biosciences | Heart Failure, Obesity | 07/25 | 09/25 | | |
NCT05485467: The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients |
|
|
| Completed | N/A | 55 | Europe | coronary CT angiography | University Medical Centre Ljubljana | Vasculopathy, Heart Transplant Failure | 08/22 | 08/22 | | |
| Recruiting | N/A | 250 | Europe | Autologous stem cell therapy | University Medical Centre Ljubljana | Cardiomyopathy, Dilated | 01/27 | 05/27 | | |
PAGNIER, Anne |
| Recruiting | 3 | 409 | Europe | Everolimus, VOTUBIA, AFINITOR, ONC201, Radiotherapy | Gustave Roussy, Cancer Campus, Grand Paris, Chimerix, Innovative Therapies For Children with Cancer Consortium, Ministry of Health, France | Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant | 09/28 | 09/31 | | |
| Recruiting | 2/3 | 536 | Europe, RoW | 16 weeks of VEC + CDDP, Vincristine, Etoposide, Cyclophosphamide, Cisplatin, VEC + HD-MTX, Methotrexate, Chemotherapy + Valproate, Carboplatin, Valproate, Conformal radiotherapy, VEC, Chemotherapy, conformal radiotherapy +/- boost | Centre Leon Berard | Childhood Ependymoma | 06/28 | 08/31 | | |
| Recruiting | 2/3 | 225 | Europe | Melphalan or Melphalan + Topotecan, Alkeran, Topotecan Accord; Topotecan Hospira chemotherapy, etoposide, carboplatin and vincristine or local ophthalmological treatment without IV chemotherapy, etoposide, carboplatin and vincristine chemotherapy, Carboplatin administered on Day 1, platinum-based chemotherapy, Thermotherapy (local treatment), Thermotherapy after carboplatin administered on Day 1, Cryotherapy (local treatment), Iodine-125 plaques (local treatment), Intravitreal Melphalan chemotherapy injections (local treatment) | Institut Curie, Fondation Rothschild Paris | Retinoblastoma | 01/35 | 01/36 | | |
| Recruiting | 2 | 185 | Europe | Observation, Low risk group, Etoposide, Intermediate risk sub group 1, Vincristine, Intermediate risk sub group 2, Orbital irradiation, High risk group, Carboplatin, Cyclophosphamide, Thiotepa, Cytapheresis, Peripheral bood stem cell transplantation | Institut Curie | Retinoblastoma | 03/30 | 09/30 | | |
| Recruiting | 2 | 134 | Europe | Trametinib, Vinblastine | University Hospital, Strasbourg, France | Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma | 11/31 | 12/31 | | |
APADHOP, NCT06230016: Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program |
|
|
| Recruiting | N/A | 48 | Europe | questionnaires, PedsQL quality of life questionnaires | University Hospital, Grenoble, University Grenoble Alps | Childhood Cancer, Adapted Physical Activity | 08/25 | 01/26 | | |
| Recruiting | N/A | 1800 | Europe | Solid tumor and CT DNA | Gustave Roussy, Cancer Campus, Grand Paris | Solid Tumor, Leukemia | 09/30 | 09/30 | | |
Poglajen, Gregor |
CELL-VAD, NCT06154044: Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support |
|
|
| Recruiting | 2 | 10 | Europe | CD34+ stem cell therapy | University Medical Centre Ljubljana | Heart Failure, Mechanical Circulatory Support | 12/24 | 05/25 | | |
| Recruiting | 2 | 90 | Europe | Letermovir Pill | University Medical Centre Ljubljana | CMV Viremia | 08/25 | 08/26 | | |
NCT05485467: The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients |
|
|
| Completed | N/A | 55 | Europe | coronary CT angiography | University Medical Centre Ljubljana | Vasculopathy, Heart Transplant Failure | 08/22 | 08/22 | | |
| Recruiting | N/A | 250 | Europe | Autologous stem cell therapy | University Medical Centre Ljubljana | Cardiomyopathy, Dilated | 01/27 | 05/27 | | |
Kitanovski, Lidija |
| Recruiting | 2/3 | 536 | Europe, RoW | 16 weeks of VEC + CDDP, Vincristine, Etoposide, Cyclophosphamide, Cisplatin, VEC + HD-MTX, Methotrexate, Chemotherapy + Valproate, Carboplatin, Valproate, Conformal radiotherapy, VEC, Chemotherapy, conformal radiotherapy +/- boost | Centre Leon Berard | Childhood Ependymoma | 06/28 | 08/31 | | |
Stupica, Daša |
NCT03462329: Patient's Pretreatment Expectations About Post-Lyme Symptoms |
|
|
| Recruiting | N/A | 200 | Europe | Antibiotics (preferentially oral doxycycline 100 mg bid) | University Medical Centre Ljubljana | Erythema Migrans | 12/24 | 12/24 | | |
NCT03956446: Tick-borne Encephalitis and Borrelial Antibodies in Serum |
|
|
| Recruiting | N/A | 80 | Europe | Doxycycline, Symptomatic therapy, Questionnaire | University Medical Centre Ljubljana, University of Ljubljana School of Medicine, Slovenia | Tick Borne Encephalitis | 12/24 | 12/24 | | |
NCT03966014: Different Amoxicillin Treatment Regimens in Erythema Migrans Patients |
|
|
| Recruiting | N/A | 510 | Europe | EM-amoxicillin 3 x 10 days, EM-amoxicillin 3 x 14 days, EM-amoxicillin 2 x 14 days, Controls | University Medical Centre Ljubljana, University of Ljubljana School of Medicine, Slovenia | Erythema Migrans | 12/25 | 12/25 | | |
NCT03337932: Duration of Doxycycline Treatment in MEM Patients |
|
|
| Recruiting | N/A | 200 | Europe | Doxycycline 100 milligram Oral Tablet bid, 7 days, Doxycycline 100 milligram Oral Tablet bid, 14 days, Controls without a history of lyme disease. | University Medical Centre Ljubljana | Erythema Chronicum Migrans | 12/24 | 12/24 | | |
Noc, Marko |
| Recruiting | N/A | 50 | Europe | P2Y12 Platelet Aggregation Inhibitor | University Medical Centre Ljubljana | Platelet Refractoriness | 06/23 | 06/23 | | |
NCT05558774: Long-term Outcomes After Percutaneous Closure of PFO |
|
|
| Recruiting | N/A | 300 | Europe | | MC Medicor, University of Ljubljana, Faculty of Medicine | Foramen Ovale, Patent, Echocardiography, Embolic Stroke, Atrial Fibrillation | 07/23 | 07/24 | | |
Bokal, Eda Vrtacnik |
NCT06804174: Comparison of Endometrial Protein Profile in Spontaneous Versus Stimulated Menstrual Cycles in Poor Responders |
|
|
| Completed | N/A | 15 | Europe | use of gonadotropins | University Medical Centre Ljubljana, Slovenian Research Agency (ARRS) | Proteome | 06/24 | 09/24 | | |
Gubensek, Jakob |
NCT05191290: Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation |
|
|
| Completed | 4 | 15 | Europe | unfractionated heparin, Sodium Citrate | University Medical Centre Ljubljana | Apheresis, Anticoagulation | 12/22 | 12/22 | | |
Pajek, Jernej |
NCT04247867: Combination of Medium Cut-off Dialyzer Membrane and Diet Modification to Alleviate Residual Uremic Syndrome of Dialysis Patients |
|
|
| Recruiting | N/A | 50 | Europe | medium cut-off (MCO) dialysis membrane, Theranova dialysis membrane (Baxter AG), Dietary fiber mixture (Plantago Psyllium and Inulin), Kolon3aktiv fiber powder (manufacturer TOPNATUR s.r.o., Czech republic), Sodium propionate | University Medical Centre Ljubljana, University of Ljubljana | End Stage Renal Disease, Haemodialysis, Diet, Healthy | 08/22 | 10/22 | | |
NCT04260412: The Effect of Combining Medium Cut Off Dialysis Membrane and Diet Modification on Reducing of Inflammation Response |
|
|
| Recruiting | N/A | 50 | Europe | medium cut-off (MCO) dialysis membrane, Theranova dialysis membrane (Baxter AG), Dietary fiber mixture (Plantago Psyllium 69% and Inulin 30%), Kolon3Aktiv (Topnatur s.r.o., Czech republic), Sodium propionate | University Medical Centre Ljubljana, University of Ljubljana | End Stage Renal Disease, Haemodialysis, Diet, Healthy, Chronic Inflammation | 08/22 | 10/22 | | |
NCT05927337: Cognitive-Behavioral Therapy for Managing Obesity in People With Chronic Kidney Disease |
|
|
| Recruiting | N/A | 60 | Europe | Cognitive Behavioral Therapy (CBT) for managing Obesity | University Medical Centre Ljubljana, Slovenian Research Agency | Chronic Kidney Diseases, Obesity, Overweight | 08/25 | 12/25 | | |
Radsel, Peter |
| Recruiting | N/A | 1022 | Europe | Early transnasal evaporative cooling with the RhinoChill device | Karolinska Institutet | Out-Of-Hospital Cardiac Arrest, Hypothermia, Ventricular Fibrillation | 02/28 | 05/28 | | |
Plut, Samo |
AMGI REGISTRY, NCT04708288: A PROSPECTIVE, MULTI-CENTER, SINGLE-ARM, POST MARKET OBSERVATIONAL STUDY TO EVALUATE THE SAFETY AND CLINICAL PERFORMANCE OF THE ARCHIMEDES BIODEGRADABLE BILIARY AND PANCREATIC STENT |
|
|
| Recruiting | N/A | 198 | Europe, RoW | ARCHIMEDES Biodegradable Biliary and Pancreatic Stent | QualiMed Innovative Medizinprodukte GmbH | Obstructed Biliary and Pancreatic Duct | 12/23 | 12/23 | | |
AmbrožiÄ, Miha |
HORAC, NCT05143853: HORizontal Instability AC Joint Study: A Prospective Randomised Clinical Trial |
|
|
| Active, not recruiting | N/A | 70 | Europe | non-absorbable tape fixation around AC joint, no fixation around AC joint, coracoclavicular (CC) fixation | University Medical Centre Ljubljana | Acromioclavicular Separation | 05/24 | 09/24 | | |
Jakob, Gregor Brecl |
| Completed | N/A | 654 | Europe | | University of Ljubljana, Novartis, General and Teaching Hospital Celje, University Medical Centre Ljubljana, University Medical Centre Maribor, Izola General Hospital | Multiple Sclerosis, Multiple Sclerosis Lesion, Multiple Sclerosis Brain Lesion | 09/23 | 09/23 | | |